The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
A Hormone–DNA Repair Circuit Governs the Response to Genotoxic Insult
Open accessAbstract
Alterations in DNA repair promote tumor development, but the impact on tumor progression is poorly understood. Here, discovery of a biochemical circuit linking hormone signaling to DNA repair and therapeutic resistance is reported. Findings show that androgen receptor (AR) activity is induced by DNA damage and promotes expression and activation of a gene expression program governing DNA repair. Subsequent investigation revealed that activated AR promotes resolution of double-strand breaks and resistance to DNA damage both in vitro and in vivo. Mechanistically, DNA-dependent protein kinase catalytic subunit (DNAPKcs) was identified as a key target of AR after damage, controlling AR-mediated DNA repair and cell survival after genotoxic insult. Finally, DNAPKcs was shown to potentiate AR function, consistent with a dual role in both DNA repair and transcriptional regulation. Combined, these studies identify the AR–DNAPKcs circuit as a major effector of DNA repair and therapeutic resistance and establish a new node for therapeutic intervention in advanced disease. Significance: The present study identifies for the first time a positive feedback circuit linking hormone action to the DNA damage response and shows the significant impact of this process on tumor progression and therapeutic response. These provocative findings provide the foundation for development of novel nodes of therapeutic intervention for advanced disease. Cancer Discov; 3(11); 1254–71. ©2013 AACR. See related commentary by Bartek et al., p. 1222 This article is highlighted in the In This Issue feature, p. 1207
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
The DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368
The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway
Lieber, M. R. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.093131 · Cited by 2,882 · cited 1×
“Direct ligation of double strand DNA breaks through NHEJ also promotes deleterious rearrangements at the break site and chromosomal translocations associated with malignancy [9].”
BackgroundDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · cited 2×
“Primarily, DDR and subsequent checkpoint activation serve as crucial mechanisms that maintain genomic stability and protect against gross genomic rearrangements that can lead to malignant conversion of normal cells [5, 6].”
BackgroundGenomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397
Development of a second-generation antiandrogen for treatment of advanced prostate cancer.
Tran, C., Ouk, S., Clegg, N. J., Chen, Y., Watson, P. A., Arora, V., Wongvipat, J., Smith-Jones, P. M., Yoo, D., Kwon, A., et al. (2009) · Science · doi:10.1126/science.1168175 · Cited by 2,292
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
Chapman, J. R., Taylor, M. R. G., & Boulton, S. J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.07.029 · Cited by 1,625
Bolla, M., Gonzalez, D., Warde, P., Dubois, J. B., Mirimanoff, R.-O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., Gil, T., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370502 · Cited by 1,548
Ward, J. F. (1988) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60611-x · Cited by 1,492
Montgomery, R. B., Mostaghel, E. A., Vessella, R., Hess, D. L., Kalhorn, T. F., Higano, C. S., True, L. D., & Nelson, P. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0249 · Cited by 1,419
Regulation of DNA double-strand break repair pathway choice
Shrivastav, M., De Haro, L. P., & Nickoloff, J. A. (2008) · Cell Research · doi:10.1038/cr.2007.111 · Cited by 1,329
Punctuated Evolution of Prostate Cancer Genomes
Baca, S. C., Prandi, D., Lawrence, M. S., Mosquera, J. M., Romanel, A., Drier, Y., Park, K., Kitabayashi, N., MacDonald, T. Y., Ghandi, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.021 · Cited by 1,320
ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation
Stiff, T., O’Driscoll, M., Rief, N., Iwabuchi, K., Löbrich, M., & Jeggo, P. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3207 · Cited by 1,014
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Wang, Q., Li, W., Zhang, Y., Yuan, X., Xu, K., Yu, J., Chen, Z., Beroukhim, R., Wang, H., Lupien, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.056 · Cited by 902
Widmark, A., Klepp, O., Solberg, A., Damber, J.-E., Angelsen, A., Fransson, P., Lund, J.-Å., Tasdemir, I., Hoyer, M., Wiklund, F., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61815-2 · Cited by 876
Yu, J., Yu, J., Mani, R.-S., Cao, Q., Brenner, C. J., Cao, X., Wang, X., Wu, L., Li, J., Hu, M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.018 · Cited by 850
A Topoisomerase IIß-Mediated dsDNA Break Required for Regulated Transcription
Ju, B.-G., Lunyak, V. V., Perissi, V., Garcia-Bassets, I., Rose, D. W., Glass, C. K., & Rosenfeld, M. G. (2006) · Science · doi:10.1126/science.1127196 · Cited by 840
Dehm, S. M., Schmidt, L. J., Heemers, H. V., Vessella, R. L., & Tindall, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0594 · Cited by 834
Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining
Mahaney, B. L., Meek, K., & Lees-Miller, S. P. (2009) · Biochemical Journal · doi:10.1042/bj20080413 · Cited by 717
Formation of the Androgen Receptor Transcription Complex
Shang, Y., Myers, M., & Brown, M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00471-9 · Cited by 672
ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Clegg, N. J., Wongvipat, J., Joseph, J. D., Tran, C., Ouk, S., Dilhas, A., Chen, Y., Grillot, K., Bischoff, E. D., Cai, L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3948 · Cited by 662
Warde, P., Mason, M., Ding, K., Kirkbride, P., Brundage, M., Cowan, R., Gospodarowicz, M., Sanders, K., Kostashuk, E., Swanson, G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61095-7 · Cited by 579
Chan, D. W., Chen, B. P.-C., Prithivirajsingh, S., Kurimasa, A., Story, M. D., Qin, J., & Chen, D. J. (2002) · Genes & Development · doi:10.1101/gad.1015202 · Cited by 479
Wang, Q., Carroll, J. S., & Brown, M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.07.018 · Cited by 450
Preclinical Evaluation of a Potent Novel DNA-Dependent Protein Kinase Inhibitor NU7441
Zhao, Y., Thomas, H. D., Batey, M. A., Cowell, I. G., Richardson, C. J., Griffin, R. J., Calvert, A. H., Newell, D. R., Smith, G. C. M., & Curtin, N. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4275 · Cited by 445
Dual Roles of PARP-1 Promote Cancer Growth and Progression
Schiewer, M. J., Goodwin, J. F., Han, S., Brenner, J. C., Augello, M. A., Dean, J. L., Liu, F., Planck, J. L., Ravindranathan, P., Chinnaiyan, A. M., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0120 · Cited by 442
Self-citationCollis, S. J., DeWeese, T. L., Jeggo, P. A., & Parker, A. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208332 · Cited by 412
Sharma, N. L., Massie, C. E., Ramos-Montoya, A., Zecchini, V., Scott, H. E., Lamb, A. D., MacArthur, S., Stark, R., Warren, A. Y., Mills, I. G., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.010 · Cited by 405
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Ni, M., Chen, Y., Lim, E., Wimberly, H., Bailey, S. T., Imai, Y., Rimm, D. L., Shirley Liu, X., & Brown, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.026 · Cited by 397
Targeting the androgen receptor pathway in prostate cancer
Chen, Y., Sawyers, C. L., & Scher, H. I. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.07.005 · Cited by 389
Targeted therapies for breast cancer
Higgins, M. J., & Baselga, J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57152 · Cited by 369
Allred, D. C., Anderson, S. J., Paik, S., Wickerham, D. L., Nagtegaal, I. D., Swain, S. M., Mamounas, E. P., Julian, T. B., Geyer, C. E., Costantino, J. P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.0141 · Cited by 361
The RAD51 gene family, genetic instability and cancer
Thacker, J. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.08.018 · Cited by 342 · cited 1×
“These results were notable, as DNAPKcs binds broken DNA ends through the Ku 70/80 heterodimer and is critical for proper recruitment of repair factors during NHEJ [1, 40], while XRCC2 and XRCC3 are RAD51 paralogs that promote strand transfer at sites of DNA damage during HR [41].”
BackgroundSharma, A., Yeow, W.-S., Ertel, A., Coleman, I., Clegg, N., Thangavel, C., Morrissey, C., Zhang, X., Comstock, C. E. S., Witkiewicz, A. K., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci44239 · Cited by 331
Self-citationChen, B. P. C., Chan, D. W., Kobayashi, J., Burma, S., Asaithamby, A., Morotomi-Yano, K., Botvinick, E., Qin, J., & Chen, D. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408827200 · Cited by 320
Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer
Knudsen, K. E., & Scher, H. I. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2660 · Cited by 307
Self-citationMinireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?
Hickey, T. E., Robinson, J. L. L., Carroll, J. S., & Tilley, W. D. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1107 · Cited by 289
Accelerated senescence: An emerging role in tumor cell response to chemotherapy and radiation
Gewirtz, D. A., Holt, S. E., & Elmore, L. W. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.024 · Cited by 281
Diverse roles of androgen receptor (AR) domains in AR-mediated signaling
Claessens, F., Denayer, S., Van Tilborgh, N., Kerkhofs, S., Helsen, C., & Haelens, A. (2008) · Nuclear Receptor Signaling · doi:10.1621/nrs.06008 · Cited by 231
Genomic instability and cancer: an introduction
Shen, Z. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq057 · Cited by 229 · cited 1×
“Failure to efficiently repair damage promotes errors in DNA replication and chromosome segregation, thus facilitating genomic instability in both hereditary and sporadic cancers [8].”
BackgroundRadiation-induced genomic instability and its implications for radiation carcinogenesis
Huang, L., Snyder, A. R., & Morgan, W. F. (2003) · Oncogene · doi:10.1038/sj.onc.1206697 · Cited by 219
Knudsen, K. E., Arden, K. C., & Cavenee, W. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20213 · Cited by 204
Self-citationTranscriptional and Nontranscriptional Functions of E2F1 in Response to DNA Damage
Biswas, A. K., & Johnson, D. G. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2196 · Cited by 179
Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86
Beskow, C., Skikuniene, J., Holgersson, Å., Nilsson, B., Lewensohn, R., Kanter, L., & Viktorsson, K. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605201 · Cited by 170
Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition
Dean, J. L., McClendon, A. K., & Knudsen, E. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365494 · Cited by 167
Self-citationHarnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes
Al‐Ejeh, F., Kumar, R., Wiegmans, A. P., Lakhani, S. R., Brown, M. P., & Khanna, K. K. (2010) · Oncogene · doi:10.1038/onc.2010.407 · Cited by 158
Urbanucci, A., Sahu, B., Seppälä, J., Larjo, A., Latonen, L., Waltering, K. K., Tammela, T., Vessella, R., Lähdesmäki, H., Jänne, O., et al. (2012) · Oncogene · doi:10.1038/onc.2011.401 · Cited by 146
Use of γH2AX and Other Biomarkers of Double-Strand Breaks During Radiotherapy
Sak, A., & Stuschke, M. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.05.004 · Cited by 142
Role of sex steroid receptors in pathobiology of hepatocellular carcinoma
Kalra, M., Mayes, J., Assefa, S., Kaul, A. K., & Kaul, R. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5945 · Cited by 141
Deans, A. J., Khanna, K. K., McNees, C. J., Mercurio, C., Heierhorst, J., & McArthur, G. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3945 · Cited by 130
Overexpression of DNA repair genes is associated with metastasis: A new hypothesis
Sarasin, A. R., & Kauffmann, A. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2007.12.002 · Cited by 101
Parker, C. C., Heinrich, D. A., O’Sullivan, J. M., Fosså, S. D., Chodacki, A., Demkow, T., Logue, J. P., Seke, M., Widmark, A., Johannessen, D. C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.5_suppl.8 · Cited by 98
Chromatin modifications and the DNA damage response to ionizing radiation
Kumar, R., Horikoshi, N., Singh, M. K., Gupta, A. K. D., Misra, H. S., Albuquerque, K., Hunt, C. R., & Pandita, T. K. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2012.00214 · Cited by 95
Deficiency in the Catalytic Subunit of DNA-Dependent Protein Kinase Causes Down-Regulation of ATM
Peng, Y., Woods, R. G., Beamish, H., Ye, R., Lees‐Miller, S. P., Lavin, M. F., & Bedford, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3451 · Cited by 95
Sharma, A. M., Comstock, C. E. S., Knudsen, E. S., Cao, K. H., Hess-Wilson, J. K., Morey, L. M., Barrera, J. G., & Knudsen, K. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4424 · Cited by 87
Self-citationMayeur, G. L., Kung, W.-J., Martinez, A. D., Izumiya, C., Chen, D. J., & Kung, H.-J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413336200 · Cited by 86
DNA-PKcs Expression Predicts Response to Radiotherapy in Prostate Cancer
Bouchaert, P., Guerif, S. G., Debiais, C., Irani, J., & Fromont, G. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.02.014 · Cited by 80
Lynam‐Lennon, N., Reynolds, J. V., Pidgeon, G. P., Lysaght, J., Marignol, L. H., & Maher, S. G. (2010) · Radiation Research · doi:10.1667/rr2295.1 · Cited by 80
Castration Therapy Results in Decreased Ku70 Levels in Prostate Cancer
Al-Ubaidi, F. L. T., Schultz, N., Loseva, O., Egevad, L., Granfors, T., & Helleday, T. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2795 · Cited by 74
Targeting the DNA damage response in oncology: past, present and future perspectives
Basu, B., Yap, T. A., Molife, L. R., & Bono, J. S. D. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32835280c6 · Cited by 68
Ogiwara, H., & Kohno, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052810 · Cited by 67
Abiraterone in Prostate Cancer: A New Angle to an Old Problem
Stein, M. N., Goodin, S., & DiPaola, R. S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1805 · Cited by 67
Klein, E. A., Ciezki, J. P., Kupelian, P. A., & Mahadevan, A. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.04.001 · Cited by 63
Weigel, N. L., Carter, T. H., Schrader, W. T., & O’Malley, B. W. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.1.1738374 · Cited by 61
Interaction of the Double-Strand Break Repair Kinase DNA-PK and Estrogen Receptor-α
Medunjanin, S., Weinert, S., Schmeißer, A., Mayer, D., & Braun-Dullaeus, R. C. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-08-0724 · Cited by 59
Asagoshi, K., Tano, K., Chastain, P. D., Adachi, N., Sonoda, E., Kikuchi, K., Koyama, H., Nagata, K., Kaufman, D. G., Takeda, S., et al. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0253 · Cited by 58
Emerging roles of DNA-PK besides DNA repair
Kong, X., Shen, Y. H., Jiang, N., Fei, X., & Mi, J. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.04.005 · Cited by 57
Medunjanin, S., Weinert, S., Poitz, D. M., Schmeißer, A., Strasser, R. H., & Braun-Dullaeus, R. C. (2010) · EMBO Reports · doi:10.1038/embor.2009.279 · Cited by 28
E2F1 and p53 Transcription Factors as Accessory Factors for Nucleotide Excision Repair
Vélez-Cruz, R., & Johnson, D. G. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131013554 · Cited by 19
The androgen receptor transcriptional program in castration-resistant prostate cancer
Roth, J., Peer, C., Price, D., & Figg, W. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.27149 · Cited by 4
Cited by
Kyriakopoulos, C. E., Chen, Y.-H., Carducci, M. A., Liu, G., Jarrard, D. F., Hahn, N. M., Shevrin, D. H., Dreicer, R., Hussain, M., Eisenberger, M., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.3657 · Cited by 1,104
Genetics and biology of prostate cancer
Wang, G., Zhao, D., Spring, D. J., & DePinho, R. A. (2018) · Genes & Development · doi:10.1101/gad.315739.118 · Cited by 750
A decade of clinical development of PARP inhibitors in perspective
Mateo, J., Lord, C. J., Serra, V., Tutt, A., Balmaña, J., Castroviejo-Bermejo, M., Cruz, C., Oaknin, A., Kaye, S. B., & de Bono, J. S. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz192 · Cited by 743
Genomic and phenotypic heterogeneity in prostate cancer
Haffner, M. C., Zwart, W., Roudier, M. P., True, L. D., Nelson, W. G., Epstein, J. I., De Marzo, A. M., Nelson, P. S., & Yegnasubramanian, S. (2021) · Nature Reviews Urology · doi:10.1038/s41585-020-00400-w · Cited by 502
Maier, P., Hartmann, L., Wenz, F., & Herskind, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010102 · Cited by 414
Metadata
- Authors
- Goodwin, J. F., Schiewer, M. J., Dean, J. L., Schrecengost, R. S., de Leeuw, R., Han, S., Ma, T., Den, R. B., Dicker, A. P., Feng, F. Y., & Knudsen, K. E.
- Venue
- Cancer Discovery
- Published
- 2013-11-01
- Volume
- 3
- Issue
- 11
- Pages
- 1254-1271
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W2118498123
- Cited by
- 364
- References
- 71
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.